Study uncovers hard-to-detect cancer mutations
New research, led by Li Ding, PhD, shows that current genome analysis approaches systematically miss detecting a certain type of complex mutation in cancer patients’ tumors. A significant percentage of these complex mutations are found in well-known cancer genes that could be targeted by existing drugs, potentially expanding the number of cancer patients who may benefit.
Kulkarni named editor-in-chief of Cancer Genetics journal
Shashikant Kulkarni, PhD, an associate professor of pathology and immunology at the School of Medicine, has been named editor-in-chief of the journal Cancer Genetics.